Novel roles for the IgG Fc glycan

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2012-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1749-6632.2011.06305.xPMID 22288459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous immunoglobulins for Alzheimer's disease.

  2014cited by this paper
• IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.

  2011cited by this paper
• The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo

  2011cited by this paper
• Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose

  2011cited by this paper
• Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's).

  2011cited by this paper
• Fc-Glycosylation of IgG1 is Modulated by B-cell Stimuli*

  2011cited by this paper
• Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway

  2011cited by this paper
• Therapeutic antibodies for autoimmunity and inflammation

  2010cited by this paper
• A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs

  2010cited by this paper
• 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.

  2010cited by this paper
• Strategies and challenges for the next generation of therapeutic antibodies

  2010cited by this paper
• Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

  2010cited by this paper
• Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy

  2010cited by this paper
• Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

  2009cited by this paper
• Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori

  2009cited by this paper
• Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study

  2009cited by this paper
• Structure of the murine unglycosylated IgG1 Fc fragment.

  2009cited by this paper
• 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.

  2009cited by this paper
• IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders

  2009cited by this paper
• Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

  2008cited by this paper
• Inaugural Article: Identification of a receptor required for the anti-inflammatory activity of IVIG

  2008cited by this paper
• Fcγ receptors as regulators of immune responses

  2008cited by this paper
• Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors

  2008cited by this paper
• Fcgamma receptors as regulators of immune responses.

  2008cited by this paper
• Anti-inflammatory actions of intravenous immunoglobulin.

  2008cited by this paper
• Decreased Pathology and Prolonged Survival of Human DC-SIGN Transgenic Mice during Mycobacterial Infection1

  2008cited by this paper
• Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality.

  2007cited by this paper
• Siglecs and their roles in the immune system

  2007cited by this paper
• C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.

  2007cited by this paper
• Detection of altered N-glycan profiles in whole serum from rheumatoid arthritis patients.

  2007cited by this paper
• C-Type Lectin DC-SIGN Modulates Toll-like Receptor Signaling via Raf-1 Kinase-Dependent Acetylation of Transcription Factor NF-κB

  2007cited by this paper
• The antiinflammatory activity of IgG: the intravenous IgG paradox

  2007cited by this paper
• Antibodies, Fc receptors and cancer.

  2007cited by this paper
• Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis.

  2007cited by this paper
• The impact of glycosylation on the biological function and structure of human immunoglobulins.

  2007cited by this paper
• Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity

  2007cited by this paper
• Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors

  2006cited by this paper
• Specificity of DC‐SIGN for mannose‐ and fucose‐containing glycans

  2006cited by this paper
• Fcgamma receptors: old friends and new family members.

  2006cited by this paper
• New Insights into the Cell Biology of the Marginal Zone of the Spleen

  2006cited by this paper
• A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.

  2006cited by this paper
• Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

  2006cited by this paper
• Enhanced Fc-dependent cellular cytotoxicity of Fc fusion proteins derived from TNF receptor II and LFA-3 by fucose removal from Asn-linked oligosaccharides.

  2006cited by this paper
• The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms.

  2006cited by this paper
• Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region.

  2005cited by this paper
• Siglecs in innate immunity.

  2005cited by this paper
• Repeated immunization induces the increase in fucose content on antigen-specific IgG N-linked oligosaccharides.

  2005cited by this paper
• Defective Microarchitecture of the Spleen Marginal Zone and Impaired Response to a Thymus-Independent Type 2 Antigen in Mice Lacking Scavenger Receptors MARCO and SR-A1

  2005cited by this paper
• Structure and function of the spleen

  2005cited by this paper
• Development and function of the splenic marginal zone.

  2004cited by this paper
• Distinct functions of DC‐SIGN and its homologues L‐SIGN (DC‐SIGNR) and mSIGNR1 in pathogen recognition and immune regulation

  2004cited by this paper
• Intravenous immunoglobulins for Alzheimer's disease.

  2004cited by this paper
• SIGN-R1 Contributes to Protection against Lethal Pneumococcal Infection in Mice

  2004cited by this paper
• Genes for peripheral neuropathy and their relevance to clinical practice

  2004cited by this paper
• High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin.

  2004cited by this paper
• DC-SIGN: escape mechanism for pathogens

  2003cited by this paper
• Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease.

  2003cited by this paper
• The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity*

  2003cited by this paper
• IVIG induces dose-dependent amelioration of ITP in rodent models.

  2003cited by this paper
• SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran.

  2003cited by this paper
• IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.

  2003cited by this paper
• Macrophages Control the Retention and Trafficking of B Lymphocytes in the Splenic Marginal Zone

  2003cited by this paper
• The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen

  2003cited by this paper
• Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function

  2003cited by this paper
• DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells

  2003cited by this paper
• Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo.

  2002cited by this paper
• Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity*

  2002cited by this paper
• Identification of Different Binding Sites in the Dendritic Cell-specific Receptor DC-SIGN for Intercellular Adhesion Molecule 3 and HIV-1*

  2002cited by this paper
• Progressive loss of cardiac sympathetic innervation in Parkinson's disease

  2002cited by this paper
• Antiinflammatory Activity of IVIG Mediated through the Inhibitory FC Receptor

  2002cited by this paper
• Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN.

  2001cited by this paper
• Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.

  2001cited by this paper
• Siglecs, sialic acids and innate immunity.

  2001cited by this paper
• Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design

  2001cited by this paper
• IgG Fc receptors.

  2001cited by this paper
• Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

  2001cited by this paper
• DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.

  2000cited by this paper
• Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.

  2000cited by this paper
• Trastuzumab: Anti‐HER2 Antibody for Treatment of Metastatic Breast Cancer

  1999cited by this paper
• Drug update: trastuzumab: anti-HER2 antibody for treatment of metastatic breast cancer.

  1999cited by this paper
• Role of the Scavenger Receptor MARCO in Alveolar Macrophage Binding of Unopsonized Environmental Particles

  1999cited by this paper
• Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo.

  1999cited by this paper
• From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins.

  1999cited by this paper
• Fucosylation of IgG heavy chains is increased in rheumatoid arthritis.

  1999cited by this paper
• IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.

  1997cited by this paper
• IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.

  1997cited by this paper
• The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines.

  1997cited by this paper
• Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

  1995cited by this paper
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

  1994cited by this paper
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

  1994cited by this paper
• Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura.

  1993cited by this paper
• Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura

  1993cited by this paper
• RAG-1-deficient mice have no mature B and T lymphocytes.

  1992cited by this paper
• Purification and properties of sialoadhesin, a sialic acid‐binding receptor of murine tissue macrophages.

  1991cited by this paper
• [The mechanism of diphtheria immunity and tetanus immunity in animals. 1890].

  1991cited by this paper
• Ultrastructural localization of a macrophage-restricted sialic acid binding hemagglutinin, SER, in macrophage-hematopoietic cell clusters.

  1990cited by this paper
• p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

  1989cited by this paper
• [Structure and function of immunoglobulins].

  1982cited by this paper
• High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

  1981cited by this paper
• Crystallographic structure studies of an IgG molecule and an Fc fragment

  1976cited by this paper

• The role of immunoglobulin E in non-atopic disorders

  2026cites this paper
• Immunoglobulin G N-glycosylation remodeling in viral infections: immunomodulatory roles and potential biomarker implications.

  2026cites this paper
• Regulation of Insulin Transcytosis Across Endothelium in Metabolic Health and Disease.

  2025cites this paper
• Interplay between the host genome, autoimmune disease and infection.

  2025cites this paper
• Establishment of reference intervals for serum immunoglobulin G N-glycosylation features in healthy Chinese adults: a nationwide survey in the framework of predictive, preventive, and personalized medicine

  2025cites this paper
• Reduction of high mannose glycoforms from monoclonal antibodies by affinity chromatography using a recombinant prokaryotic lectin.

  2025cites this paper
• Immunoglobulin G glycosylation and its alterations in aging-related diseases

  2024cites this paper
• Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-Inflammatory Pathways.

  2024cites this paper
• IgG4 glycosylation contributes to the pathogenesis of IgG4 Hashimoto’s thyroiditis via the complement pathway

  2024cites this paper
• Bovine Colostrum in Pediatric Nutrition and Health

  2024cites this paper
• A multiplexed microflow LC–MS/MS-PRM assay for serologic quantification of IgG N- and HPX O- glycoforms in liver fibrosis

  2023cites this paper
• The role of glycosylation in clinical allergy and immunology.

  2023cites this paper
• Genetic control of N-glycosylation of human blood plasma proteins

  2023cites this paper
• FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis

  2023cites this paper
• The role of N-glycosylation in B-cell biology and IgG activity. The aspects of autoimmunity and anti-inflammatory therapy

  2023cites this paper
• Fc N‐glycosylation of autoreactive Aβ antibodies as a blood‐based biomarker for Alzheimer's disease

  2023cites this paper
• Different effects of the methods of administering lactoferrin, IGF ‐1 and IgG from bovine colostrum to rabbits based on the cytokine communication network

  2023cites this paper
• LC-MS/MS-PRM Quantification of IgG Glycoforms Using Stable Isotope Labeled IgG1 Fc Glycopeptide Standard

  2023cites this paper
• Investigating a Boronate-Affinity Guided Acylation Reaction for Labelling Native Antibodies.

  2022cites this paper
• Changes of IgG N-Glycosylation in Thyroid Autoimmunity: The Modulatory Effect of Methimazole in Graves’ Disease and the Association With the Severity of Inflammation in Hashimoto’s Thyroiditis

  2022cites this paper
• A Novel Insight Into the Etiology of Haff Disease by Mapping N-Glycome With Orthogonal Mass Spectrometry

  2022cites this paper
• HIV-associated alterations of the biophysical features of maternal antibodies correlate with their reduced transfer across the placenta.

  2022cites this paper
• Comparative analysis of plant transient expression vectors for targeted N-glycosylation

  2022cites this paper
• LC-MS/MS-PRM Quantification of IgG glycoforms using stable isotope labeled IgG1 Fc glycopeptide standard

  2022cites this paper
• Pregnancy enables antibody protection against intracellular infection

  2022cites this paper
• Loss of α-gal during primate evolution enhanced antibody-effector function and resistance to bacterial sepsis.

  2021cites this paper
• Synthesis of PNGase-resistant N-glycopeptide containing an α-anomeric glycosidic linkage

  2021cites this paper
• Genetic glycoengineering in mammalian cells

  2021cites this paper
• Glycans in Immunologic Health and Disease.

  2021cites this paper
• IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints

  2020cites this paper
• IgA subclasses have different effector functions associated with distinct glycosylation profiles

  2020cites this paper
• A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet.

  2020cites this paper
• Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs

  2020influential citation
• Glycosylation decreases aggregation and immunogenicity of adalimumab fab secreted from Pichia pastoris.

  2020cites this paper
• Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases

  2020cites this paper
• A trade-off between resistance to infection and reproduction in primate evolution

  2020influential citation
• Life-Style Related Disease and Aging

  2019cites this paper
• Serum amyloid P and a DC-SIGN ligand inhibit high fat diet-induced adipose tissue and liver inflammation and steatosis in mice.

  2019cites this paper
• Sialic acid metabolism as a potential therapeutic target of atherosclerosis

  2019cites this paper
• Glycoscience: Basic Science to Applications: Insights from the Japan Consortium for Glycobiology and Glycotechnology (JCGG)

  2019cites this paper
• The History of IgG Glycosylation and Where We Are Now.

  2019influential citation
• Recombinant human monoclonal HLA antibodies of different IgG subclasses recognising the same epitope: Excellent tools to study differential effects of donor‐specific antibodies

  2019cites this paper
• Chemical biology of glycoproteins: From chemical synthesis to biological impact.

  2019cites this paper
• Effect of the total galactose content on complement-dependent cytotoxicity of the therapeutic anti-CD20 IgG1 antibodies under temperature stress conditions

  2019cites this paper
• Non-canonical B cell functions in transplantation.

  2019cites this paper
• Dynamic Aspects of the Immunoglobulin Structure

  2019cites this paper
• The Ligands for Human IgG and Their Effector Functions

  2019cites this paper
• ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation

  2019cites this paper
• Human DC-SIGN and CD23 do not interact with human IgG

  2019cites this paper
• Next-Generation (Glycomic) Biomarkers for Cardiometabolic Health: A Community-Based Study of Immunoglobulin G N-Glycans in a Chinese Han Population

  2019cites this paper
• ICAM3-Fc outperforms receptor-specific antibodies targeted nanoparticles to dendritic cells for cross-presentation

  2019cites this paper
• Serum Amyloid P and a Dendritic CelleSpecific Intercellular Adhesion Molecule-3eGrabbing Nonintegrin Ligand Inhibit High-Fat DieteInduced Adipose Tissue and Liver Inflammation and Steatosis in Mice

  2019cites this paper
• IgG Fc N-glycosylation: Alterations in neurologic diseases and potential therapeutic target?

  2019cites this paper
• Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis

  2019cites this paper
• IgG Fc Glycosylation Patterns of Preterm Infants Differ With Gestational Age

  2019cites this paper
• Supplementation with the Sialic Acid Precursor N-acetyl-D-Mannosamine Breaks the Link Between Obesity and Hypertension.

  2019cites this paper
• IgG Fc Receptors: Evolutionary Considerations.

  2019cites this paper
• Glycoengineering of Antibodies for Modulating Functions.

  2019cites this paper
• Emerging glycobiology tools: A renaissance in accessibility.

  2018cites this paper
• N-glikozilacija imunoglobulina G u upalnim bolestima crijeva

  2018cites this paper
• Altered Fc galactosylation in IgG4 is a potential serum marker for chronic lung disease

  2018cites this paper
• Glycoengineered antibodies: towards the next-generation of immunotherapeutics

  2018cites this paper
• Predicting relapses in ANCA associated vasculitis

  2018cites this paper
• Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.

  2018cites this paper
• Neutrophil Activation by Antibody Receptors

  2018cites this paper
• The role of B cells in atherosclerosis

  2018cites this paper
• Using Chemical Synthesis To Study and Apply Protein Glycosylation.

  2018cites this paper
• Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody

  2018cites this paper
• IgG N-glycans as potential biomarker of chronological and biological ages : A community-based study in a Han Chinese population

  2018cites this paper
• Fcγ Receptor Heterogeneity in Leukocyte Functional Responses

  2017cites this paper
• Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis

  2017cites this paper
• Autoantibodies: Opportunities for Early Cancer Detection.

  2017cites this paper
• Antibody Glycosylation Predicts Relapse in Autoimmune Vasculitis

  2017cites this paper
• Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model

  2017cites this paper
• Development and evaluation of a library of thiazoline-sugar based inhibitors

  2017cites this paper
• Fcγ Receptor Function and the Design of Vaccination Strategies.

  2017cites this paper
• A Potential Improved Anti-HIV Drug: Using a Bivalent Design to Increase Specificity and Potency

  2017cites this paper
• Antibody blood-brain barrier efflux is modulated by glycan modification.

  2017cites this paper
• Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins

  2017cites this paper
• Effects of immunomodulators on the response induced by vaccines against autoimmune diseases

  2017cites this paper
• IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis

  2017cites this paper
• Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI

  2017cites this paper
• N-glycosylation profile of the protective chimeric antibody ch14D5a against tick-borne encephalitis virus

  2017cites this paper
• Diversification of IgG effector functions

  2017cites this paper
• The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease

  2017cites this paper
• IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity

  2017cites this paper
• Proteomic and metabolomic approaches in inflammatory lung diseases

  2017cites this paper
• Hyposialylated IgG activates endothelial IgG receptor Fc&ggr;RIIB to promote obesity-induced insulin resistance

  2017cites this paper
• Modulators of IgG penetration through the blood-brain barrier: Implications for Alzheimer's disease immunotherapy

  2017cites this paper
• Engineered IgG1‐Fc – one fragment to bind them all

  2016cites this paper
• Intravenous Immunoglobulin Suppresses Abortion Relates to an Increase in the CD44bright NK Subset in Recurrent Pregnancy Loss Model Mice1

  2016cites this paper
• New therapies for hemophilia.

  2016cites this paper
• Correlating the Impact of Well-Defined Oligosaccharide Structures on Physical Stability Profiles of IgG1-Fc Glycoforms.

  2016cites this paper
• Capillary Electrophoresis of Proteins and Peptides

  2016cites this paper
• Capillary Electrophoresis Method for the Assessment of Erythropoiesis-Stimulating Agents in Final Formulations.

  2016cites this paper
• Profiling IgG N-glycans as potential biomarker of chronological and biological ages

  2016cites this paper
• Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies

  2016cites this paper
• Sialylation of antibodies in kidney recipients with de novo donor specific antibody, with or without antibody mediated rejection.

  2016cites this paper
• A community-based study in a Han Chinese population

  2016cites this paper
• Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine

  2016cites this paper